241 related articles for article (PubMed ID: 16155368)
1. Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes.
Dominguez H; Storgaard H; Rask-Madsen C; Steffen Hermann T; Ihlemann N; Baunbjerg Nielsen D; Spohr C; Kober L; Vaag A; Torp-Pedersen C
J Vasc Res; 2005; 42(6):517-25. PubMed ID: 16155368
[TBL] [Abstract][Full Text] [Related]
2. Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus.
Martínez-Abundis E; Reynoso-von Drateln C; Hernández-Salazar E; González-Ortiz M
Arch Dermatol Res; 2007 Nov; 299(9):461-5. PubMed ID: 17726611
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans.
Rask-Madsen C; Domínguez H; Ihlemann N; Hermann T; Køber L; Torp-Pedersen C
Circulation; 2003 Oct; 108(15):1815-21. PubMed ID: 14530204
[TBL] [Abstract][Full Text] [Related]
4. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers.
Lima MM; Pareja JC; Alegre SM; Geloneze SR; Kahn SE; Astiarraga BD; Chaim ÉA; Baracat J; Geloneze B
Obesity (Silver Spring); 2013 Mar; 21(3):E182-9. PubMed ID: 23404948
[TBL] [Abstract][Full Text] [Related]
5. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
Tack CJ; Ong MK; Lutterman JA; Smits P
Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone.
Martens FM; Rabelink TJ; op 't Roodt J; de Koning EJ; Visseren FL
Eur Heart J; 2006 Jul; 27(13):1605-9. PubMed ID: 16762982
[TBL] [Abstract][Full Text] [Related]
7. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437
[TBL] [Abstract][Full Text] [Related]
8. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
[TBL] [Abstract][Full Text] [Related]
9. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
[TBL] [Abstract][Full Text] [Related]
10. Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance.
Caballero AE; Bousquet-Santos K; Robles-Osorio L; Montagnani V; Soodini G; Porramatikul S; Hamdy O; Nobrega AC; Horton ES
Diabetes Care; 2008 Mar; 31(3):576-82. PubMed ID: 18083792
[TBL] [Abstract][Full Text] [Related]
11. Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis.
Cardillo C; Schinzari F; Mores N; Mettimano M; Melina D; Zoli A; Ferraccioli G
Clin Pharmacol Ther; 2006 Sep; 80(3):275-81. PubMed ID: 16952494
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of insulin action and tumor necrosis factor alpha system activity by metformin.
Biarnés J; Fernández-Real JM; Fernández-Castañer M; del Mar García M; Soler J; Ricart W
Metabolism; 2005 Feb; 54(2):235-9. PubMed ID: 15690319
[TBL] [Abstract][Full Text] [Related]
13. Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus.
Tesauro M; Rizza S; Iantorno M; Campia U; Cardillo C; Lauro D; Leo R; Turriziani M; Cocciolillo GC; Fusco A; Panza JA; Scuteri A; Federici M; Lauro R; Quon MJ
Metabolism; 2007 Mar; 56(3):413-9. PubMed ID: 17292732
[TBL] [Abstract][Full Text] [Related]
14. Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade.
van Eijk IC; Peters MJ; Serné EH; van der Horst-Bruinsma IE; Dijkmans BA; Smulders YM; Nurmohamed MT
Ann Rheum Dis; 2009 Mar; 68(3):362-6. PubMed ID: 18390569
[TBL] [Abstract][Full Text] [Related]
15. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.
Ohara S; Komatsu R; Matsuyama T
Diabetes Res Clin Pract; 2004 Nov; 66(2):133-8. PubMed ID: 15533580
[TBL] [Abstract][Full Text] [Related]
16. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.
Madhusudan S; Foster M; Muthuramalingam SR; Braybrooke JP; Wilner S; Kaur K; Han C; Hoare S; Balkwill F; Talbot DC; Ganesan TS; Harris AL
Clin Cancer Res; 2004 Oct; 10(19):6528-34. PubMed ID: 15475440
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects.
Zhang Y; Han P; Wu N; He B; Lu Y; Li S; Liu Y; Zhao S; Liu L; Li Y
Obesity (Silver Spring); 2011 Aug; 19(8):1647-53. PubMed ID: 21593803
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction.
Nyström T; Nygren A; Sjöholm A
Clin Sci (Lond); 2006 Jun; 110(6):673-81. PubMed ID: 16466346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
